Literature DB >> 11720861

Discovery, total synthesis, HRV 3C-protease inhibitory activity, and structure-activity relationships of 2-methoxystypandrone and its analogues.

S B Singh1, P L Graham, R A Reamer, M G Cordingley.   

Abstract

2-Methoxystypandrone, a naphthoquinone, was isolated from a Chinese herb Polygonum cuspidatum by bioassay guided fractionation using HRV 3C-protease assay. It showed an IC(50) value of 4.6 microM and is moderately selective. A new 10-step, total synthesis of 2-methoxystypandrone was accomplished in 45% overall yield using a Diels-Alder approach. Several analogues of this compound were prepared. Isolation, synthesis and HRV 3C-protease structure-activity relationships of these compounds have been described.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11720861     DOI: 10.1016/s0960-894x(01)00648-5

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  5 in total

Review 1.  Review of the chemistry and pharmacology of 7-Methyljugulone.

Authors:  Armelle T Mbaveng; Victor Kuete
Journal:  Afr Health Sci       Date:  2014-03       Impact factor: 0.927

2.  2-Methoxystypandrone represses RANKL-mediated osteoclastogenesis by down-regulating formation of TRAF6-TAK1 signalling complexes.

Authors:  W F Chiou; J F Liao; C Y Huang; C C Chen
Journal:  Br J Pharmacol       Date:  2010-09       Impact factor: 8.739

3.  2-Methoxystypandrone inhibits signal transducer and activator of transcription 3 and nuclear factor-κB signaling by inhibiting Janus kinase 2 and IκB kinase.

Authors:  Shan Kuang; Chunting Qi; Jiawei Liu; Xiaoxiao Sun; Qing Zhang; Zhenhua Sima; Jingli Liu; Wuguo Li; Qiang Yu
Journal:  Cancer Sci       Date:  2014-03-03       Impact factor: 6.716

4.  2-Ethoxystypandrone, a novel small-molecule STAT3 signaling inhibitor from Polygonum cuspidatum, inhibits cell growth and induces apoptosis of HCC cells and HCC Cancer stem cells.

Authors:  Wuguo Li; Qing Zhang; Kaotan Chen; Zhenhua Sima; Jingli Liu; Qiang Yu; Jiawei Liu
Journal:  BMC Complement Altern Med       Date:  2019-02-01       Impact factor: 3.659

Review 5.  The human rhinovirus: human-pathological impact, mechanisms of antirhinoviral agents, and strategies for their discovery.

Authors:  Judith M Rollinger; Michaela Schmidtke
Journal:  Med Res Rev       Date:  2011-01       Impact factor: 12.944

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.